TCT 518: Final 5-year report of the randomized BIONYX trial assessing Onyx versus Orsiro drug-eluting stents in all-comers
We Recommend
Disclosures
Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:
- Grant Support/Research Contract - Abbott Vascular; Biotronik; Boston Scientific Corporation; Medtronic